Absence of pathogenic viruses in <scp>COVID</scp> ‐19 convalescent plasma-Reference-Cited by-同舟云学术

Absence of pathogenic viruses in COVID ‐19 convalescent plasma

Published:2022-11-03 Issue:1 Volume:63 Page:23-29
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Kandathil Abraham J.¹^ORCID,Benner Sarah E.²,Bloch Evan M.²^ORCID,Shrestha Ruchee²,Ajayi Olivia²,Zhu Xianming²^ORCID,Caturegli Patrizio P.²,Shoham Shmuel¹,Sullivan David¹³,Gebo Kelly¹,Quinn Thomas C.¹⁴,Casadevall Arturo³,Hanley Daniel⁵,Pekosz Andrew¹³,Redd Andrew D.¹⁴,Balagopal Ashwin¹,Tobian Aaron A. R.¹²

Affiliation:

1. Division of Infectious Diseases, Department of Medicine Johns Hopkins School of Medicine, Johns Hopkins University Baltimore Maryland USA

2. Department of Pathology, Johns Hopkins School of Medicine Johns Hopkins University Baltimore Maryland USA

3. Department of Molecular Microbiology and Immunology Bloomberg School of Public Health, Johns Hopkins University Baltimore Maryland USA

4. Division of Intramural Research National Institute of Allergy and Infectious Diseases, National Institutes of Health Bethesda Maryland USA

5. Department of Neurology Johns Hopkins School of Medicine, Johns Hopkins University Baltimore Maryland USA

Funder

Division of Intramural Research, National Institute of Allergy and Infectious Diseases

National Institutes of Health

U.S. Department of Defense

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/trf.17168

Reference30 articles.

1. A randomized double-blind controlled trial of convalescent plasma in adults with severe COVID-19

2. Early Convalescent Plasma for High-Risk Outpatients with Covid-19

3. Transfusing Convalescent Plasma as Post-Exposure Prophylaxis Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Double-Blinded, Phase 2 Randomized, Controlled Trial

4. Early Outpatient Treatment for Covid-19 with Convalescent Plasma

5. Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Convalescent plasma therapy in COVID-19: Unravelling the data using the principles of antibody therapy;Expert Review of Respiratory Medicine;2023-05-02